Atopobium vaginae, BVAB2 and Megasphaera
Atopobium vaginae (Fannyhessea vaginae); BV-associated bacterium 2 (BVAB2); Megasphaera type 1; Megasphaera type 2
General medical information for education only, not medical advice. Treatment considerations summarize published guidance at drug-class level; therapy is chosen by the treating clinician using susceptibility results, local resistance patterns and current guidelines.
Overview
Anaerobic bacteria strongly associated with bacterial vaginosis; molecular assays use them, together with Gardnerella and lactobacilli, to characterize the vaginal microbiome.
Infections
Bacterial vaginosis, the most common cause of abnormal vaginal discharge. Associated with preterm birth, pelvic inflammatory disease and a higher risk of acquiring sexually transmitted infections.
Signs and symptoms
Thin gray-white discharge and a fishy odor, often more noticeable after sex. Many people have no symptoms. Itching and inflammation are uncommon and suggest another cause.
Antibiotic and antimicrobial resistance
Atopobium vaginae may be less susceptible to metronidazole.
Treatment considerations
Treated as bacterial vaginosis with metronidazole or clindamycin, per the CDC STI treatment guidelines. Atopobium (Fannyhessea) vaginae is often less susceptible to metronidazole, which may contribute to recurrence.
Sources
- CDC. Bacterial vaginosis (STI Treatment Guidelines).
- CDC. Sexually Transmitted Infections Treatment Guidelines, 2021.
Sources accessed November 2026. Links open external sites that InnovexLab does not control.
Medical disclaimer
This page is general educational information summarized from published public-health and professional-society guidance. It is not medical advice, a diagnosis or a treatment recommendation, and reading it does not create a clinician–patient relationship with InnovexLab. Decisions about testing, diagnosis and treatment belong to the treating clinician, using the patient’s history and examination, laboratory and susceptibility results, local resistance patterns and current guidelines. Guidance changes over time; consult the original sources for the latest version. InnovexLab provides this information as is and does not warrant that it is complete or current.
Patients with questions about their health should contact their own healthcare provider. In an emergency, call 911.